| Opportunities to improve the care of patients with kidney transplant failure. | |
| | |
MedLine Citation:
|
PMID: 12028460 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Patients initiating dialysis after a failed kidney transplant are a subgroup of chronic kidney disease (CKD) patients who have not been characterized. Exposure to immunosuppressive medications differentiates these patients from the general incident end-stage renal disease (ESRD) population. METHODS: Data from the Health Care Financing Administration 2728 form were used to determine the hematocrit, erythropoietin use, serum albumin and glomerular filtration rate (GFR) among 4643 patients with failed kidney transplants who initiated dialysis between April 1995 and December 1998. RESULTS: At dialysis initiation, the mean hematocrit, serum albumin and GFR were 27.5%, 3.3 g/dL, and 8.4 mL/min/1.73 m2, respectively, and only 35% of patients had received erythropoietin. In a multivariate analysis, patients <45 years, females, patients of non-White race, non-diabetic patients, hemodialysis patients and patients with a lower serum albumin had a higher odds for hematocrit <30%. Erythropoietin use was associated with female gender, White race, increased time since transplantation, being employed, peritoneal dialysis, and higher serum albumin. Patients >/=45 years and patients with diabetes or congestive heart failure had higher odds for hypoalbuminemia, while employed patients, peritoneal dialysis patients, patients with higher hematocrit and patients who had received erythropoietin had lower odds of hypoalbuminemia. CONCLUSIONS: Despite being known to specialty physicians, patients with failed kidney transplants initiate dialysis at levels of hematocrit, serum albumin, and GFR that may be suboptimal and similar to those in the general incident ESRD population. Socioeconomic factors remain important barriers to the provision of CKD care even among these patients with established specialty physician contact. Improved CKD care could improve the outcomes of this unique subgroup of CKD patients. |
| | |
Authors:
|
John S Gill; Rekha Abichandani; Samina Khan; Annamaria T Kausz; Brian J G Pereira |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Kidney international Volume: 61 ISSN: 0085-2538 ISO Abbreviation: Kidney Int. Publication Date: 2002 Jun |
Date Detail:
|
Created Date: 2002-05-24 Completed Date: 2002-10-21 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0323470 Medline TA: Kidney Int Country: United States |
Other Details:
|
Languages: eng Pagination: 2193-200 Citation Subset: IM |
Affiliation:
|
Division of Nephrology, New England Medical Center, Boston, Massachusetts 02111, USA. Bpereira@lifespan.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Erythropoietin / therapeutic use Female Glomerular Filtration Rate Hematocrit Humans Kidney Transplantation* Male Middle Aged Quality of Health Care* Renal Dialysis Retreatment Serum Albumin / analysis Treatment Failure |
| Grant Support | |
ID/Acronym/Agency:
|
1KO8 DK 02745/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Serum Albumin; 11096-26-7/Erythropoietin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Advanced atherosclerosis in predialysis patients with chronic renal failure.
Next Document: Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis.